SIGNAL Trial
SIGNAL Trial
信号试验
批准号：
nhmrc : GNT1042474
负责人：
A/Pr Meg Jardine
金额：
$268.16万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2013
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2013-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
IgA nephropathy is one of the most common causes of kidney failure in Australia and around the world, but there are currently no specific treatments proven to prevent kidney failure. The SIGNAL trial, jointly led by Australian and Chinese researchers, will bring together leading experts from around the world to reliably ascertain the effects of steroid therapy in this condition, and could potentially prevent many people from developing kidney failure in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and optimising the delivery of chronic disease care for better cardiovascular outcomes
-
批准号：nhmrc : 1149366
-
项目类别：Career Development Fellowships
-
资助金额：$32.23万
-
财政年份：2018
-
负责人：A/Pr Meg Jardine
-
依托单位：
Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes
-
批准号：nhmrc : 1127085
-
项目类别：Project Grants
-
资助金额：$133.84万
-
财政年份：2017
-
负责人：A/Pr Meg Jardine
-
依托单位：
Evidence for interventions that improve cardiovascular outcomes in chronic kidney disease
-
批准号：nhmrc : 1065769
-
项目类别：Career Development Fellowships
-
资助金额：$28.12万
-
财政年份：2014
-
负责人：A/Pr Meg Jardine
-
依托单位：
Better cardiovascular outcomes in kidney disease
-
批准号：nhmrc : GNT1065769
-
项目类别：Career Development Fellowships
-
资助金额：$27.0万
-
财政年份：2014
-
负责人：A/Pr Meg Jardine
-
依托单位：
The SIGNAL Trial: Steroids in ImmunoGlobulin A Nephropathy: Assessment of Long term outcomes
-
批准号：nhmrc : 1042474
-
项目类别：Project Grants
-
资助金额：$186.98万
-
财政年份：2013
-
负责人：A/Pr Meg Jardine
-
依托单位：
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验：The ASCVD Risk Intervention Trial
-
批准号：81973152
-
项目类别：面上项目
-
资助金额：54.0万元
-
批准年份：2019
-
负责人：胡东生
-
依托单位：
